Ephedra Imports Legal While Nutraceutical Appeal Underway – Emord
This article was originally published in The Tan Sheet
Executive Summary
FDA's refusal to allow Hong Kong-based broker EMAX to import ephedra-containing dietary supplements into the U.S. violates an April 2005 court ruling which invalidated the agency's ban on the botanical, according to a lawsuit filed April 21 by the firm Emord & Associates
You may also be interested in...
FDA “Misrepresented” Ephedra Dosing With Use Of Old Label In Court – Emord
FDA lawyers misrepresented product labeling for Nutraceutical Corporation's ephedra dietary supplements to a Utah appeals court by referencing a discontinued label that instructed consumers to take high doses of the product, according to law firm Emord & Associates
FDA “Misrepresented” Ephedra Dosing With Use Of Old Label In Court – Emord
FDA lawyers misrepresented product labeling for Nutraceutical Corporation's ephedra dietary supplements to a Utah appeals court by referencing a discontinued label that instructed consumers to take high doses of the product, according to law firm Emord & Associates
FDA “Misrepresented” Ephedra Dosing With Use Of Old Label In Court – Emord
FDA lawyers misrepresented product labeling for Nutraceutical Corporation's ephedra dietary supplements to a Utah appeals court by referencing a discontinued label that instructed consumers to take high doses of the product, according to law firm Emord & Associates